Akzo Nobel India Ltd Upgraded to Hold as Technicals Improve Amid Mixed Financials

Quality Assessment: Management Efficiency and Financial Health

Akzo Nobel India continues to demonstrate strong management efficiency, as evidenced by its robust Return on Equity (ROE) of 24.90%, signalling effective utilisation of shareholder capital. The company maintains a conservative capital structure with an average Debt to Equity ratio of zero, underscoring a low leverage position that reduces financial risk. However, the company’s operational performance has been relatively flat in the recent quarter (Q3 FY25-26), with net sales declining by 7.0% to ₹907.70 crores compared to the previous four-quarter average.

Return on Capital Employed (ROCE) for the half-year period stands at a modest 22.13%, the lowest in recent times, while cash and cash equivalents have dropped to ₹282.80 crores, indicating tighter liquidity. These factors suggest that while the company’s quality metrics remain solid, there are signs of operational stagnation and cautious financial management.

Valuation: Attractive Yet Premium Pricing

From a valuation perspective, Akzo Nobel India presents a mixed picture. The stock trades at a Price to Book (P/B) ratio of 6, which is relatively high compared to its peers’ historical averages, indicating a premium valuation. Despite this, the company’s ROE of 17.4% supports this premium, suggesting that investors are paying for quality returns. Additionally, the stock offers a compelling dividend yield of 6.5%, which is attractive in the current market environment and provides income support to shareholders.

However, the stock’s one-year return of -17.56% significantly underperforms the broader market benchmark BSE500, which declined by only 2.30% over the same period. This underperformance, coupled with a 12.1% fall in profits over the last year, tempers enthusiasm and justifies a cautious valuation stance.

Financial Trend: Flat Performance Amidst Market Challenges

Akzo Nobel India’s financial trend over recent quarters has been largely flat, with the latest quarter showing no significant growth. Net sales have grown at an annualised rate of 11.10% over the past five years, while operating profit has increased at 14.25% annually, indicating moderate long-term growth. However, the recent quarterly decline of 7.0% in net sales and a 12.1% drop in profits over the last year highlight near-term headwinds.

Promoter confidence appears to be waning, with a notable reduction in promoter stake by 8.56% in the previous quarter, now standing at 61.2%. This decrease may reflect concerns about the company’s growth prospects or strategic direction. Furthermore, the stock has underperformed the Sensex and BSE500 indices over the last year, with a return of -17.56% compared to the Sensex’s -5.18% and BSE500’s -2.30%, respectively.

Technicals: Shift from Bearish to Mildly Bearish Outlook

The upgrade in Akzo Nobel India’s investment rating is primarily driven by improvements in its technical indicators. The technical trend has shifted from bearish to mildly bearish, signalling a potential stabilisation in price movement. Key technical metrics present a mixed but cautiously optimistic picture:

• MACD: Weekly remains bearish, but monthly has improved to mildly bearish.
• RSI: Both weekly and monthly show no clear signal, indicating neutral momentum.
• Bollinger Bands: Weekly and monthly trends are mildly bearish, suggesting reduced volatility pressure.
• Moving Averages: Daily moving averages are mildly bearish, reflecting short-term caution.
• KST (Know Sure Thing): Weekly is bearish, monthly mildly bearish, indicating some momentum loss but less severe than before.
• Dow Theory: Weekly is mildly bullish, while monthly shows no trend, hinting at emerging positive price action.
• On-Balance Volume (OBV): Weekly is mildly bullish, but monthly remains bearish, reflecting mixed investor participation.

Price-wise, the stock closed at ₹2,948.80, up 0.87% from the previous close of ₹2,923.45, with a day’s trading range between ₹2,860.05 and ₹2,951.95. The 52-week high and low stand at ₹3,909.25 and ₹2,649.05, respectively, indicating the stock is trading closer to its lower band but showing signs of recovery.

Comparative Returns and Market Context

Examining Akzo Nobel India’s returns relative to the Sensex reveals a mixed performance. Over the past week, the stock outperformed the Sensex with a 2.41% gain versus the Sensex’s 1.27% loss. Over one month, the stock’s return was a modest 0.49%, outperforming the Sensex’s steep decline of 9.48%. Year-to-date, the stock has fallen 7.06%, but this is still better than the Sensex’s 13.66% decline.

However, over the one-year horizon, the stock’s return of -17.56% significantly lags the Sensex’s -5.18%. Longer-term returns over three, five, and ten years show the stock has delivered 27.08%, 32.58%, and 132.39% respectively, trailing the Sensex’s 27.63%, 50.14%, and 190.41% returns. This indicates that while the company has delivered respectable long-term growth, it has underperformed the broader market, particularly in recent years.

Conclusion: A Cautious Upgrade Reflecting Mixed Signals

The upgrade of Akzo Nobel India Ltd’s investment rating from Sell to Hold reflects a cautious optimism driven primarily by technical improvements and a stable valuation supported by strong management efficiency. Despite flat recent financial performance, low leverage, and attractive dividend yield, the company faces challenges including declining sales, reduced promoter confidence, and underperformance relative to the market.

Technical indicators suggest the stock may be stabilising after a bearish phase, but momentum remains subdued. Investors should weigh the company’s solid quality metrics and dividend appeal against its valuation premium and recent profit declines. The Hold rating signals that while the stock is no longer a sell, it does not yet warrant a Buy recommendation given the mixed financial and market signals.

Limited Period Only. Get Started for only Rs. 16,999 - Get MojoOne for 2 Years + 1 Year Absolutely FREE! (72% Off) Get 72% Off →